Journal
Future Oncology
Publication Date
12-1-2024
Volume
20
Issue
39
First Page
3213
Last Page
3227
Document Type
Open Access Publication
DOI
10.1080/14796694.2024.2418285
Rights and Permissions
Bazhenova L, Kim DW, Cho BC, Goel S, Heist R, Werner TL, Eaton KD, Wang JS, Pant S, Adkins DR, Blakely CM, Yan X, Neuteboom S, Christensen JG, Chao R, Bauer T. Sitravatinib in patients with solid tumors selected by molecular alterations: results from a Phase Ib study. Future Oncol. 2024 Dec;20(39):3213-3227. doi: 10.1080/14796694.2024.2418285. © 2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.
Recommended Citation
Bazhenova, Lyudmila; Adkins, Douglas R; and et al., "Sitravatinib in patients with solid tumors selected by molecular alterations: Results from a Phase Ib study." Future Oncology. 20, 39. 3213 - 3227. (2024).
https://digitalcommons.wustl.edu/oa_4/4545
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
